Refine
Year of publication
Document Type
- Article (75)
- Contribution to a Periodical (5)
- Preprint (4)
- Working Paper (1)
Has Fulltext
- yes (85)
Is part of the Bibliography
- no (85)
Keywords
- COVID-19 (4)
- SARS-CoV-2 (4)
- AIS (1)
- ALK (1)
- ALK-rearranged NSCLC (1)
- ARDS (1)
- Advanced biliary tract cancer (1)
- Artificial Intelligence (1)
- BESIII (1)
- BTC (1)
- Biodiversity Data (1)
- Biomedical engineering (1)
- Biomonitoring (1)
- Botanical Collections (1)
- Brain tumor (1)
- Branching fractions (1)
- CHEPs (1)
- COVID (1)
- CVD biomarker (1)
- Cancer (1)
- Capsaicin (1)
- Cardiac implantable electronic devices (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy (1)
- Chest pain unit (1)
- Consensus document (1)
- Conservation (1)
- Coronary intervention (1)
- Critical care (1)
- Digitization (1)
- D⁰ meson (1)
- EWSR1 (1)
- Exercise training (1)
- Gene fusion (1)
- Genetic testing (1)
- Genetics (1)
- Genome-wide association studies (1)
- Geschichtsunterricht (1)
- Hadronic decays (1)
- Hand-foot syndrome (1)
- Health information (1)
- Health-seeking behaviour (1)
- Heart failure (1)
- Helpline (1)
- Herbaria (1)
- Hif1α (1)
- ICU (1)
- ISS (1)
- Immunology (1)
- Implantable cardioverter-defibrillator (1)
- Judenvernichtung (1)
- K48-linked (1)
- K63-linked (1)
- Liver cirrhosis (1)
- MN1 (1)
- MYCN amplification (1)
- Membrane protein (1)
- NMR spectroscopy (1)
- NSTEMI (1)
- Nanodisc (1)
- Nationalsozialismus (1)
- Neuroepithelial (1)
- Neurooncology (1)
- Outcome (1)
- PATZ1 (1)
- PDGFRβ (1)
- Pacemaker (1)
- Pediatric (1)
- Pharmacodynamics (1)
- Physical activity (1)
- Pneumonia (1)
- Portal hypertension (1)
- Preclinical research (1)
- Prevention (1)
- Primary prophylaxis (1)
- Prognosis (1)
- Prognostic models (1)
- RAS pathway (1)
- Rare diseases (1)
- Research Infrastructure (1)
- Resonance assignment (1)
- Rheumatoid arthritis (1)
- Semantics (1)
- Solution-state NMR (1)
- Sorafenib (1)
- Spontaneous bacterial peritonitis (1)
- TP53 mutation status (1)
- Target validation (1)
- Taxonomy (1)
- Telemedicine (1)
- Thoracic trauma (1)
- Unterrichtsmethode (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Viral infection (1)
- accessory proteins (1)
- accident (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- c-kit (1)
- cell stress (1)
- cell-free protein synthesis (1)
- geriatric medicine (1)
- health information exchange (1)
- high-risk neuroblastoma (1)
- injury (1)
- intrinsically disordered region (1)
- lockdown (1)
- microwave ablation (1)
- neurological manifestations (1)
- neutralizing antibodies (1)
- nonstructural proteins (1)
- oval split ring resonator (1)
- p53 pathway (1)
- pediatric intensive care (1)
- polyubiquitin (1)
- qualitative research (1)
- quality control (1)
- rare diseases (1)
- resectability (1)
- risk factor progression (1)
- risk factors (1)
- sequential ALK-inhibitor therapy (1)
- spike protein (1)
- structural proteins (1)
- theranostics (1)
- trauma (1)
- ubiquitin-conjugating enzymes (1)
- variants of concern (1)
Institute
The highly infectious disease COVID-19 caused by the Betacoronavirus SARS-CoV-2 poses a severe threat to humanity and demands the redirection of scientific efforts and criteria to organized research projects. The international COVID19-NMR consortium seeks to provide such new approaches by gathering scientific expertise worldwide. In particular, making available viral proteins and RNAs will pave the way to understanding the SARS-CoV-2 molecular components in detail. The research in COVID19-NMR and the resources provided through the consortium are fully disclosed to accelerate access and exploitation. NMR investigations of the viral molecular components are designated to provide the essential basis for further work, including macromolecular interaction studies and high-throughput drug screening. Here, we present the extensive catalog of a holistic SARS-CoV-2 protein preparation approach based on the consortium’s collective efforts. We provide protocols for the large-scale production of more than 80% of all SARS-CoV-2 proteins or essential parts of them. Several of the proteins were produced in more than one laboratory, demonstrating the high interoperability between NMR groups worldwide. For the majority of proteins, we can produce isotope-labeled samples of HSQC-grade. Together with several NMR chemical shift assignments made publicly available on covid19-nmr.com, we here provide highly valuable resources for the production of SARS-CoV-2 proteins in isotope-labeled form.
Background and objectives: Our study aimed at examining the long-time inflammatory effects of rheumatoid arthritis (RA) as chronic immune-mediated disease on pain sensation and neuropathy development compared to healthy subjects (HS).
Methods: We used the quantitative sensory testing (QST) protocol of the German Research Network on Neuropathic Pain and Electroencephalography (EEG)–based contact heat evoked potentials (CHEPs) before and after topical capsaicin application. We recruited 16 RA patients in remission or low disease activity state (mean age: 59.38 years [± 10.18]) and 16 healthy subjects (mean age: 56.69 years [± 8.92]).
Results: The application of capsaicin cream on the thigh provoked a stronger effect in HS for both mechanical and heat pain thresholds (MPT and HPT, resp.), according to the area under the receiver operation characteristic (AUROC) (HS: HPT: 0.8965, MPT: 0.7402; RA: HPT: 0.7012, MPT: 0.6113). We observed contrary effects regarding changes in CHEPs (HS: g*max = − 0.65; RA patients: g*max = 0.72).
Conclusion: As the overall effect of topical capsaicin application was higher in HS for QST, we suggest the existence of a sensitization of TRPV1 channels in RA patients caused by long-time chronical inflammation, despite a lack of clinical signs of inflammation due to adequate treatment. The effect in CHEPs probably uncovers neuropathic symptoms. The effect of topical capsaicin on HPTs and CHEPs can act as a marker for the extent of sensitization and the development of neuropathic symptoms. Further studies are needed to prove if our proposed method can act as a marker for the success of anti-inflammatory treatment.
The nuclear factor kappa beta (NFκB) signaling pathway plays an important role in liver homeostasis and cancer development. Tax1-binding protein 1 (Tax1BP1) is a regulator of the NFκB signaling pathway, but its role in the liver and hepatocellular carcinoma (HCC) is presently unknown. Here we investigated the role of Tax1BP1 in liver cells and murine models of HCC and liver fibrosis. We applied the diethylnitrosamine (DEN) model of experimental hepatocarcinogenesis in Tax1BP1+/+ and Tax1BP1−/− mice. The amount and subsets of non-parenchymal liver cells in in Tax1BP1+/+ and Tax1BP1−/− mice were determined and activation of NFκB and stress induced signaling pathways were assessed. Differential expression of mRNA and miRNA was determined. Tax1BP1−/− mice showed increased numbers of inflammatory cells in the liver. Furthermore, a sustained activation of the NFκB signaling pathway was found in hepatocytes as well as increased transcription of proinflammatory cytokines in isolated Kupffer cells from Tax1BP1−/− mice. Several differentially expressed mRNAs and miRNAs in livers of Tax1BP1−/− mice were found, which are regulators of inflammation or are involved in cancer development or progression. Furthermore, Tax1BP1−/− mice developed more HCCs than their Tax1BP1+/+ littermates. We conclude that Tax1BP1 protects from liver cancer development by limiting proinflammatory signaling.
The catalytic mechanism, electron transfer coupled to proton pumping, of heme-copper oxidases is not yet fully understood. Microsecond freeze-hyperquenching single turnover experiments were carried out with fully reduced cytochrome aa(3) reacting with O(2) between 83 micros and 6 ms. Trapped intermediates were analyzed by low temperature UV-visible, X-band, and Q-band EPR spectroscopy, enabling determination of the oxidation-reduction kinetics of Cu(A), heme a, heme a(3), and of a recently detected tryptophan radical (Wiertz, F. G. M., Richter, O. M. H., Cherepanov, A. V., MacMillan, F., Ludwig, B., and de Vries, S. (2004) FEBS Lett. 575, 127-130). Cu(B) and heme a(3) were EPR silent during all stages of the reaction. Cu(A) and heme a are in electronic equilibrium acting as a redox pair. The reduction potential of Cu(A) is 4.5 mV lower than that of heme a. Both redox groups are oxidized in two phases with apparent half-lives of 57 micros and 1.2 ms together donating a single electron to the binuclear center in each phase. The formation of the heme a(3) oxoferryl species P(R) (maxima at 430 nm and 606 nm) was completed in approximately 130 micros, similar to the first oxidation phase of Cu(A) and heme a. The intermediate F (absorbance maximum at 571 nm) is formed from P(R) and decays to a hitherto undetected intermediate named F(W)(*). F(W)(*) harbors a tryptophan radical, identified by Q-band EPR spectroscopy as the tryptophan neutral radical of the strictly conserved Trp-272 (Trp-272(*)). The Trp-272(*) populates to 4-5% due to its relatively low rate of formation (t((1/2)) = 1.2 ms) and rapid rate of breakdown (t((1/2)) = 60 micros), which represents electron transfer from Cu(A)/heme a to Trp-272(*). The formation of the Trp-272(*) constitutes the major rate-determining step of the catalytic cycle. Our findings show that Trp-272 is a redox-active residue and is in this respect on an equal par to the metallocenters of the cytochrome c oxidase. Trp-272 is the direct reductant either to the heme a(3) oxoferryl species or to Cu (2+)(B). The potential role of Trp-272 in proton pumping is discussed.
Invasive treatment of NSTEMI patients in German chest pain units – evidence for a treatment paradox
(2018)
Background: Patients with non ST-segment elevation myocardial infarction (NSTEMI) represent the largest fraction of patients with acute coronary syndrome in German Chest Pain units. Recent evidence on early vs. selective percutaneous coronary intervention (PCI) is ambiguous with respect to effects on mortality, myocardial infarction (MI) and recurrent angina. With the present study we sought to investigate the prognostic impact of PCI and its timing in German Chest Pain Unit (CPU) NSTEMI patients.
Methods and results: Data from 1549 patients whose leading diagnosis was NSTEMI were retrieved from the German CPU registry for the interval between 3/2010 and 3/2014. Follow-up was available at median of 167 days after discharge. The patients were grouped into a higher (Group A) and lower risk group (Group B) according to GRACE score and additional criteria on admission. Group A had higher Killip classes, higher BNP levels, reduced EF and significant more triple vessel disease (p < 0.001). Surprisingly, patients in group A less frequently received early diagnostic catheterization and PCI. While conservative management did not affect prognosis in Group B, higher-risk CPU-NSTEMI patients without PCI had a significantly worse survival.
Conclusions: The present results reveal a substantial treatment gap in higher-risk NSTEMI patients in German Chest Pain Units. This treatment paradox may worsen prognosis in patients who could derive the largest benefit from early revascularization.